EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 183 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,359,000 | +4.3% | 72,136 | -4.9% | 0.02% | -53.5% |
| Q3 2020 | $3,222,000 | +33.5% | 75,836 | +50.8% | 0.04% | +126.3% |
| Q2 2020 | $2,413,000 | -99.9% | 50,296 | -2.3% | 0.02% | -17.4% |
| Q1 2020 | $2,369,000,000 | -30.8% | 51,496 | -9.6% | 0.02% | 0.0% |
| Q4 2019 | $3,424,000,000 | +102661.1% | 56,996 | -3.2% | 0.02% | 0.0% |
| Q3 2019 | $3,332,000 | +0.8% | 58,896 | -0.8% | 0.02% | 0.0% |
| Q2 2019 | $3,307,000 | +22.4% | 59,396 | +11.0% | 0.02% | +21.1% |
| Q1 2019 | $2,701,000 | +26.0% | 53,496 | +0.6% | 0.02% | +5.6% |
| Q4 2018 | $2,143,000 | -27.3% | 53,196 | +25.2% | 0.02% | -14.3% |
| Q3 2018 | $2,946,000 | – | 42,496 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 112,666 | $1,777 | 0.65% |
| Smith, Graham & Co., Investment Advisors, LP | 273,099 | $4,306,771 | 0.54% |
| BRANDES INVESTMENT PARTNERS, LP | 1,134,363 | $17,888,904 | 0.35% |
| TANG CAPITAL MANAGEMENT LLC | 118,857 | $1,874,375 | 0.26% |
| Virtus Investment Advisers, Inc. | 20,867 | $329,073 | 0.22% |
| DENALI ADVISORS LLC | 32,300 | $509,371 | 0.18% |
| Nebula Research & Development LLC | 11,473 | $180,929 | 0.10% |
| SCOUT INVESTMENTS, INC. | 131,192 | $1,995,430 | 0.05% |
| XTX Topco Ltd | 15,050 | $237,339 | 0.04% |
| PDT Partners, LLC | 19,745 | $311,379 | 0.04% |